CD9 and neoplasm: In addition, CD9 divided CD11b+cDC2s into two subgroups in B16-F10 tumor-bearing mice, namely CD9–(CD301–)/CD9+(CD301+)CD11b+cDC2s, which are required for activating antitumor CD4+ Tconv (Binnewies et al., 2019).